Skip to main content

Table 1 Patient characteristics at initiation of second line ART (numbers in brackets = interquartile range)

From: Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study

No of females

54.4% (149/125)

Median age in years

35 (32 – 42)

Median CD4 at baseline (n = 251)

174 (107 – 265)

Median log10 VL at baseline (n = 261)

4.1 (3.6 – 4.7)

Median no of months followed up

27 (15 – 47)